Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?
<strong>Objectives:</strong> Controlled immune responses rely on integrated crosstalk between cells and their microenvironment. We investigated whether targeting proinflammatory signals from the extracellular matrix that persist during pathological inflammation provides a viable strategy...
| Príomhchruthaitheoirí: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formáid: | Journal article |
| Foilsithe / Cruthaithe: |
BMJ Publishing Group
2018
|